Desq Long
Sign in

Company

Structure Therapeutics Inc.

GPCR · CIK 0001888886

SEC FORM 4
$0.00

Structure Therapeutics Inc. (GPCR)

Disposition (code C) of 12,024 shares at $0 per share.

Reporting Person Coll Crespo Blas · Officer Title CHIEF MEDICAL OFFICER · Transaction Code C

Traded Sep 21, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0002037144-26-000004 · filed 2026-09-22 · View filing →

SEC FORM 4
$124,005.42

Structure Therapeutics Inc. (GPCR)

Disposition (code F) of 10,626 shares at $11.67 per share.

Reporting Person Coll Crespo Blas · Officer Title CHIEF MEDICAL OFFICER · Transaction Code F

Traded Sep 18, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0002037144-26-000004 · filed 2026-09-22 · View filing →

SEC FORM 4
$6,057.78

Structure Therapeutics Inc. (GPCR)

Acquisition (code M) of 17,817 shares at $0.34 per share.

Reporting Person Lin Xichen · Officer Title CHIEF SCIENTIFIC OFFICER · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001962926-26-000009 · filed 2026-09-02 · View filing →

SEC FORM 4
$0.00

Structure Therapeutics Inc. (GPCR)

Disposition (code C) of 17,817 shares at $0 per share.

Reporting Person Lin Xichen · Officer Title CHIEF SCIENTIFIC OFFICER · Transaction Code C

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001962926-26-000009 · filed 2026-09-02 · View filing →

SEC FORM 4
$4,017.78

Structure Therapeutics Inc. (GPCR)

Acquisition (code M) of 11,817 shares at $0.34 per share.

Reporting Person Lin Xichen · Officer Title CHIEF SCIENTIFIC OFFICER · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001962926-26-000008 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

Structure Therapeutics Inc. (GPCR)

Disposition (code C) of 11,817 shares at $0 per share.

Reporting Person Lin Xichen · Officer Title CHIEF SCIENTIFIC OFFICER · Transaction Code C

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001962926-26-000008 · filed 2026-08-19 · View filing →